MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates
Globe Newswire•06/08/2026•08:19 ET
0
Whiz Insights
Get started
Create a free account to read the full story.